BioPharmSignal logoBioPharmSignal

Biotech News

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

Certara (CERT)Certara2026-06-25 13:46 ESTEarnings

FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj. EBITDA of $32.5M (-3% decline) FY 2026 Revenue Growth of 0-4% FY 2026 Adjusted EBITDA Margin of 30-32% FY 2026 Adjusted Diluted EPS of $0.44-$0.48 RADNOR, Pa., Feb.

Open original release

Related news

CERTCertara2026-06-25 13:46 EST

Certara Announces CFO Transition

CERTCertara2026-06-25 13:46 EST

Certara Reports First Quarter 2026 Financial Results

CERTCertara2026-06-25 13:46 EST

Certara Automates Scientific Workflows with Phoenix® Cloud

CERTCertara2026-06-25 13:46 EST

Certara Reports Third Quarter 2025 Financial Results

CERTCertara2026-06-25 13:46 EST

Certara Appoints Jon Resnick as Chief Executive Officer

CERTCertara2026-06-25 13:46 EST

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026

CERTCertara2026-06-25 13:46 EST

Certara to Participate in Upcoming Investor Conferences

CERTCertara2026-06-25 13:46 EST

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

CERTCertara2026-06-25 13:46 EST

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

CERTCertara2026-06-25 13:46 EST

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

View all latest news

Certara

Certara is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

CERTCertara2026-06-26 11:31 EST

Certara Announces CFO Transition

CERTCertara2026-06-26 11:31 EST

Certara Reports First Quarter 2026 Financial Results

CERTCertara2026-06-26 11:31 EST

Certara Automates Scientific Workflows with Phoenix® Cloud

CERTCertara2026-06-26 11:31 EST

Certara Reports Third Quarter 2025 Financial Results

CERTCertara2026-06-26 11:31 EST

Certara Appoints Jon Resnick as Chief Executive Officer

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States